Delivery Order HHSN272201700052I-75N93021F00001

Award Date 2/10/21
Potential Completion Date 9/30/24
Potential Value $171K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $148,507.78 delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned for-profit organization. The contract is part of the Vaccine Research Center (VRC) Clinical Monitoring Initiative 2017-2024, an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle that allows NIAID to rapidly procure...
This is a $77,993 cost-plus-fixed-fee delivery order awarded to Technical Resources International, Inc. (TRI) by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency. The contract is part of the larger VRC Clinical Monitoring Initiative 2017-2024 indefinite delivery vehicle (IDV). TRI, a minority-owned, woman-owned, and Hispanic American-owned small business, will provide clinical monitoring services for the Vaccine Research Center (VRC) HIV Clinical Monitoring...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) has awarded a delivery order to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business, to provide clinical monitoring services for the VRC 612 malaria vaccine research program. The $337,707 delivery order is part of the larger $545 million NIAID Clinical Monitoring Initiative...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, Hispanic American-owned small business. The $99,420.00 award is a Delivery Order under the VRC Clinical Monitoring Initiative 2017-2024 indefinite delivery vehicle (IDV), which has a potential value of $545.4 million. The contract is for clinical monitoring services in support of the VRC...
This is a delivery order (TO #133) awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, Hispanic American-owned small business. The $47,964.64 cost-plus-fixed-fee delivery order is for clinical research support services related to malaria research and was issued under NIAID's $545 million Clinical and Regulatory Research and...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, to Technical Resources International, Inc. (doing business as Technical Resources Intl), a minority-owned, woman-owned, Hispanic American-owned small business. The contract has a ceiling value of $47,222.87 and is for a clinical trial for vaccine candidates VRC 609, VRC 610, and VRC 018. This delivery order is...
This is a $6,335,456.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business. The contract is for regulatory operations support services and has a period of performance through March 30, 2030. TRI has extensive experience supporting...
This is a federal contract award by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, Hispanic American-owned small business. The contract, valued at $164,128,686.00, is for the NIAID/DAIDS Regulatory Support Center and has an ultimate completion date of April 14, 2031. The contract type is Delivery Order with a Cost Plus Fixed Fee pricing...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Technical Resources International, Inc. (Technical Resources Intl), a minority-owned, woman-owned, Hispanic American-owned small business. The $152,341.00 cost-plus-fixed-fee contract is a delivery order under the VRC Clinical Monitoring Initiative 2017-2024 multiple-award IDIQ contract, which covers clinical trials program support for the Vaccine Research Center. The...
This is a $32,180,191.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, Hispanic American-owned small business. The contract is for DAIDS Quality Assurance, Quality Control and Inspection Readiness Support Services, and is not set aside. TRI has extensive experience supporting biomedical research initiatives for various...

This is a delivery order awarded to Technical Resources International, Inc. (TRI) by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) for the CLINICAL MONITORING INITIATIVE (CMI) VACCINE RESEARCH CENTER (VRC) 325 MOSAIC QUADRIVALENT INFLUENZA VACCINE project. The order is part of the VRC Clinical Monitoring Initiative 2017-2024 indefinite delivery/indefinite quantity (IDIQ) contract and has a potential value of $170,894.00. TRI, a for-profit, minority-owned, and woman-owned small business, will provide clinical trials execution, management, and research support services for this influenza vaccine research and development effort. The contract does not have a set-aside designation.

Generated 3/20/24, 5:59 PM